Evidence map›Paper›PMID 32437569›Full record

Trial reportNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2020

Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients.

Augustine W Kang, Andrew G Bostom, Hongseok Kim, Charles B Eaton, Reginald Gohh, John W Kusek, Marc A Pfeffer, Patricia M Risica, Carol E Garber

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Augustine W KangCenter for Health Equity Research, Brown University School of Public Health, Providence, RI, USA.
Andrew G BostomDepartment of Family Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Hongseok KimDepartment of Epidemiology, Brown University School of Public Health, Providence, RI, USA.
Charles B EatonDepartment of Family Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Reginald GohhDivision of Nephrology, Rhode Island Hospital, Providence, RI, USA.
John W KusekDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Marc A PfefferDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Patricia M RisicaCenter for Health Equity Research, Brown University School of Public Health, Providence, RI, USA.
Carol E GarberTeachers' College, Columbia University, New York, NY, USA.
Brown University · USBrigham and Women's Hospital · USColumbia University · USProvidence College · USUniversity of Pennsylvania · US

Funding

Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) TrialU01DK061700 · NIDDK · TUFTS MEDICAL CENTER · PI BOSTOM, ANDREW G. · 2001 to 2011
$29.0M
NIDDK NIH HHS U01 DK061700
6 · The paper itself

Abstract

backgroundInsufficient physical activity (PA) may increase the risk of all-cause mortality and cardiovascular disease (CVD) morbidity and mortality among kidney transplant recipients (KTRs), but limited research is available. We examine the relationship between PA and the development of CVD events, CVD death and all-cause mortality among KTRs.

methodsA total of 3050 KTRs enrolled in an international homocysteine-lowering randomized controlled trial were examined (38% female; mean age 51.8 ± 9.4 years; 75% white; 20% with prevalent CVD). PA was measured at baseline using a modified Yale Physical Activity Survey, divided into tertiles (T1, T2 and T3) from lowest to highest PA. Kaplan-Meier survival curves were used to graph the risk of events; Cox proportional hazards regression models examined the association of baseline PA levels with CVD events (e.g. stroke, myocardial infarction), CVD mortality and all-cause mortality over time.

resultsParticipants were followed up to 2500 days (mean 3.7 ± 1.6 years). The cohort experienced 426 CVD events and 357 deaths. Fully adjusted models revealed that, compared to the lowest tertile of PA, the highest tertile experienced a significantly lower risk of CVD events {hazard ratio [HR] 0.76 [95% confidence interval (CI) 0.59-0.98]}, CVD mortality [HR 0.58 (95% CI 0.35-0.96)] and all-cause mortality [HR 0.76 (95% CI 0.59-0.98)]. Results were similar in unadjusted models.

conclusionsPA was associated with a reduced risk of CVD events and all-cause mortality among KTRs. These observed associations in a large, international sample, even when controlling for traditional CVD risk factors, indicate the potential importance of PA in reducing CVD and death among KTRs.

Indexed as

Exercise TherapyAdultAgedCardiovascular DiseasesCohort StudiesFemaleHumansKidney TransplantationMaleMiddle AgedPrognosisRisk FactorsSurvival Ratecardiovascular disease riskkidney transplant recipientsmortality riskphysical activitysurvival analysis

Identifiers

PMID32437569
PMCPMC7828582
OpenAlexW3026291436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.